Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
physicians sometimes recommend alternating sites to minimize local accumulation
Ideal candidates for leading with NAD+: Patients over 40 experiencing persistent fatigue that does not resolve with sleep or lifestyle changes Individuals with metabolic syndrome, insulin resistance, or difficulty managing weight despite dietary effort Patients recovering from substance use, where NAD+ IV therapy has shown measurable benefit in reducing withdrawal symptoms and cravings High-performance athletes or executives seeking cognitive edge and faster physical recovery Patients with early neurodegenerative concerns who want evidence-supported mitochondrial support GHK-Cu Dosage and NAD+ Dosage: What Clinical Protocols Actually Use Dosing varies based on delivery route, patient body weight, and clinical goal
We focus on transparency, consistency, and long-term support so customers get reliable care without guesswork, pressure, or unnecessary complexity
Following transected quadriceps muscle injury, BPC-157 promotes complete functional recovery by stimulating myogenesis through release of specific growth factors that contribute to injured myofibril regeneration
GHK-Cu works through different mechanisms than most peptides and produces distinct effects on skin tissue
US$ 27.63
US$ 29.44
US$ 20.64
